Stephens Investment Management Group LLC lessened its stake in shares of Cerner Corporation (NASDAQ:CERN) by 0.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 474,688 shares of the company’s stock after selling 4,320 shares during the period. Stephens Investment Management Group LLC owned 0.14% of Cerner Corporation worth $33,855,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of CERN. Vanguard Group Inc. boosted its holdings in shares of Cerner Corporation by 3.1% in the 2nd quarter. Vanguard Group Inc. now owns 29,296,545 shares of the company’s stock valued at $1,947,341,000 after purchasing an additional 876,919 shares in the last quarter. BlackRock Inc. lifted its holdings in Cerner Corporation by 0.8% during the 2nd quarter. BlackRock Inc. now owns 18,436,042 shares of the company’s stock worth $1,225,441,000 after buying an additional 137,320 shares during the period. Bank of New York Mellon Corp lifted its holdings in Cerner Corporation by 19.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 17,546,618 shares of the company’s stock worth $1,166,325,000 after buying an additional 2,800,955 shares during the period. FMR LLC lifted its holdings in Cerner Corporation by 0.8% during the 2nd quarter. FMR LLC now owns 5,652,931 shares of the company’s stock worth $375,750,000 after buying an additional 43,521 shares during the period. Finally, American Century Companies Inc. lifted its holdings in Cerner Corporation by 62.4% during the 2nd quarter. American Century Companies Inc. now owns 3,929,394 shares of the company’s stock worth $261,187,000 after buying an additional 1,510,288 shares during the period. Hedge funds and other institutional investors own 80.30% of the company’s stock.

Shares of Cerner Corporation (CERN) traded up $0.33 during midday trading on Tuesday, hitting $65.73. The stock had a trading volume of 1,887,700 shares, compared to its average volume of 2,357,683. Cerner Corporation has a 12-month low of $47.01 and a 12-month high of $73.86. The stock has a market cap of $22,020.00, a P/E ratio of 28.94, a PEG ratio of 2.10 and a beta of 0.93. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75.

Cerner Corporation (NASDAQ:CERN) last posted its quarterly earnings data on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing the consensus estimate of $0.62 by ($0.01). Cerner Corporation had a net margin of 13.37% and a return on equity of 18.03%. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter in the previous year, the company posted $0.59 EPS. Cerner Corporation’s revenue for the quarter was up 7.7% on a year-over-year basis. research analysts expect that Cerner Corporation will post 2.26 earnings per share for the current fiscal year.

In related news, SVP Randy D. Sims sold 60,000 shares of the company’s stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $68.03, for a total value of $4,081,800.00. Following the transaction, the senior vice president now owns 60,890 shares in the company, valued at $4,142,346.70. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Clifford W. Illig sold 140,000 shares of the company’s stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $65.52, for a total value of $9,172,800.00. Following the completion of the transaction, the chief executive officer now owns 1,229,719 shares in the company, valued at approximately $80,571,188.88. The disclosure for this sale can be found here. In the last quarter, insiders sold 927,470 shares of company stock worth $61,604,482. 13.20% of the stock is owned by company insiders.

Several research analysts have recently weighed in on CERN shares. Royal Bank Of Canada reissued a “buy” rating on shares of Cerner Corporation in a research report on Wednesday, October 25th. Robert W. Baird reissued a “hold” rating and issued a $67.00 price objective on shares of Cerner Corporation in a research report on Thursday, August 31st. Cantor Fitzgerald reissued a “buy” rating and issued a $77.00 price objective on shares of Cerner Corporation in a research report on Tuesday, October 10th. J P Morgan Chase & Co lowered Cerner Corporation from an “overweight” rating to a “neutral” rating in a research report on Friday, October 27th. Finally, Zacks Investment Research lowered Cerner Corporation from a “buy” rating to a “sell” rating in a research report on Tuesday, October 31st. One equities research analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and nine have given a buy rating to the stock. Cerner Corporation presently has a consensus rating of “Hold” and a consensus target price of $70.00.

ILLEGAL ACTIVITY WARNING: This piece was reported by Watch List News and is owned by of Watch List News. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/stephens-investment-management-group-llc-sells-4320-shares-of-cerner-corporation-cern/1717902.html.

About Cerner Corporation

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Institutional Ownership by Quarter for Cerner Corporation (NASDAQ:CERN)

Receive News & Ratings for Cerner Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.